Visión generalGráficoNoticiasTraderScreen

Morgan Stanley Knock-Out ZLAB/  DE000MG3V7R7  /

Stuttgart
12/11/2024  17:10:00 Diferencia- Bid22:00:37 Ask22:00:37 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
1.36EUR - -
Volumen de oferta: -		 -
Tamaño/ Volumen/ Formato de Ask: -		 Zai Lab Ltd 13.8966 USD 31/12/2078 Call
GlobeNewswire 06/08 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
GlobeNewswire 31/07 Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacyclin...
GlobeNewswire 25/07 argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update
GlobeNewswire 18/07 Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Stu...
GlobeNewswire 16/07 argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Ge...
GlobeNewswire 01/06 Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipa...
GlobeNewswire 09/05 argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 18/04 Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated P...
GlobeNewswire 10/04 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire 06/03 Crescendo Biologics to present at the 2024 AACR Annual Meeting
GlobeNewswire 05/03 Paratek Pharmaceuticals Announces Positive Efficacy Data for NUZYRA® as Post-Exposure Prophylaxis of...
GlobeNewswire 29/02 argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
GlobeNewswire 14/02 Genmab Publishes 2023 Annual Report
GlobeNewswire 16/01 Paratek Pharmaceuticals Announces Promotion of Jonathan Light to General Counsel, Corporate Secretar...
GlobeNewswire 08/01 argenx Highlights 2024 Strategic Priorities
GlobeNewswire 04/01 Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
GlobeNewswire 13/12/2023 Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug L...
GlobeNewswire 06/12/2023 Crescendo Biologics announces first U.S. patients dosed in expanded Phase 1b clinical trial of CB307...
GlobeNewswire 07/11/2023 Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
GlobeNewswire 31/10/2023 argenx Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 26/10/2023 Zai Lab Announces Participation in November Investor Conferences
GlobeNewswire 18/10/2023 Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7,...
GlobeNewswire 05/10/2023 Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023
GlobeNewswire 21/09/2023 Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.
GlobeNewswire 18/09/2023 Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and No...